RecruitingPhase 4

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

United States56 participantsStarted 2024-08-19

Plain-language summary

Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Orthopedics service patients having reverse shoulder replacement surgery
✓. ASA class I, II, or III.
✓. Patients at least 18 years old but less than 90 years old.
✓. Patients giving informed consent.
✓. Non-Emergency Surgery

Exclusion criteria

✕. An inability to cooperate during the block placement.
✕. Patients who do not meet criteria for a regional block: such as those on anti-coagulation,
✕. Significant pulmonary disease or allergy to medications used for peripheral nerve blocks (Exparel, Bupivacaine and Ropivacaine)
✕. Neuropathy of the planned extremity to block
✕. Documented Kidney Failure
✕. Documented Liver Failure
✕. A lack of or inability to give informed consent.
✕. Currently incarcerated.

What they're measuring

Pain Score Assessed by functional pain score at POD 1

Timeframe: The primary outcome will occur at 1 day after surgery date

Trial details

NCT IDNCT05868330

SponsorMelinda Seering

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10

Contact for this trial

Melinda Seering, MD

5156895508 melinda-seering@uiowa.edu

View on ClinicalTrials.gov More Post Operative Pain trials